Citation Impact
Citing Papers
Drug ratio–dependent antitumor activity of irinotecan and cisplatin combinations in vitro and in vivo
2009
Progress and challenges towards targeted delivery of cancer therapeutics
2018 Standout
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come
2016
Nano-based smart pesticide formulations: Emerging opportunities for agriculture
2018 Standout
Nanoparticles evading the reticuloendothelial system: Role of the supported bilayer
2009
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Sterically stabilized superparamagnetic liposomes for MR imaging and cancer therapy: Pharmacokinetics and biodistribution
2007
The role of liposomes in clinical nanomedicine development. What now? Now what?
2019 Standout
Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles
2013
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
Interaction of Liposomal Formulations of Meta‐tetra(hydroxyphenyl)chlorin (Temoporfin) with Serum Proteins: Protein Binding and Liposome Destruction
2012
Clinical development and potential of photothermal and photodynamic therapies for cancer
2020 Standout
Therapeutic Efficacy Evaluation of111In-Labeled PEGylated Liposomal Vinorelbine in Murine Colon Carcinoma with Multimodalities of Molecular Imaging
2009
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
Delivery of nanomedicines to extracellular and intracellular compartments of a solid tumor
2011
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
2021 StandoutNobel
Targeting nanoparticles to cancer
2010
Stimuli-responsive nanocarriers for drug delivery
2013 Standout
Folate-targeted PEGylated liposomes improve the selectivity of PDT with meta-tetra(hydroxyphenyl)-chlorin (m-THPC)
2013
Physico-chemical parameters that govern nanoparticles fate also dictate rules for their molecular evolution
2011
Complement activation by PEGylated single-walled carbon nanotubes is independent of C1q and alternative pathway turnover
2008
Comparative studies of polyethylene glycol-modified liposomes prepared using different PEG-modification methods
2012
Cryogenic transmission electron microscopy (cryo-TEM) for studying the morphology of colloidal drug delivery systems
2011
Delivery technologies for cancer immunotherapy
2019 Standout
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
2010 Standout
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
2015 Standout
Elucidating the assembled structure of amphiphiles in solution via cryogenic transmission electron microscopy
2007
Nanoliposomal irinotecan plus fluorouracil and folinic acid: a new treatment option in metastatic pancreatic cancer
2016
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
2009 Standout
Advances and Challenges of Liposome Assisted Drug Delivery
2015 Standout
Drug nanocrystallisation within liposomes
2018
The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
2010 Standout
Pharmacological and physical vessel modulation strategies to improve EPR-mediated drug targeting to tumors
2017
Tumor delivery of macromolecular drugs based on the EPR effect
2010 Standout
Strategies in the design of nanoparticles for therapeutic applications
2010 Standout
Designing hydrogels for controlled drug delivery
2016 Standout
The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo
2012 Standout
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Liposome triggering of innate immune responses: A perspective on benefits and adverse reactions
2009
Ligand-targeted liposome design: challenges and fundamental considerations
2013
Liposomes as nanomedical devices
2015 Standout
Biomolecular coronas provide the biological identity of nanosized materials
2012 Standout
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
2016 Standout
A new nanoconstruct for epidermal growth factor receptor-targeted photo-immunotherapy of ovarian cancer
2013
Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions
2021 Standout
Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers
2016 Standout
The utility of asymmetric flow field-flow fractionation for preclinical characterization of nanomedicines
2019
Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems
2011
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Natural products against cancer angiogenesis
2016
Tumor-Targeted Nanomedicines: Enhanced Antitumor Efficacy In vivo of Doxorubicin-Loaded, Long-Circulating Liposomes Modified with Cancer-Specific Monoclonal Antibody
2009
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Photoremovable Protecting Groups in Chemistry and Biology: Reaction Mechanisms and Efficacy
2012 Standout
Photoexpulsion of Surface-Grafted Ruthenium Complexes and Subsequent Release of Cytotoxic Cargos to Cancer Cells from Mesoporous Silica Nanoparticles
2013 StandoutNobel
Nanoscale Metal–Organic Frameworks for Biomedical Imaging and Drug Delivery
2011 Standout
PEGylated PRINT Nanoparticles: The Impact of PEG Density on Protein Binding, Macrophage Association, Biodistribution, and Pharmacokinetics
2012
Pharmacokinetics and Biodistribution of Nanoparticles
2008
Impact of Surface Polyethylene Glycol (PEG) Density on Biodegradable Nanoparticle Transport in Mucus ex Vivo and Distribution in Vivo
2015
Cationic Thermosensitive Liposomes: A Novel Dual Targeted Heat-Triggered Drug Delivery Approach for Endothelial and Tumor Cells
2012
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Ruthenium-Decorated Lipid Vesicles: Light-Induced Release of [Ru(terpy)(bpy)(OH2)]2+ and Thermal Back Coordination
2010
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Nanoparticles in Photodynamic Therapy
2015 Standout
Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems
2018 Standout
Immunological and Toxicological Considerations for the Design of Liposomes
2020
Clinical translation of immunoliposomes for cancer therapy: recent perspectives
2018
Copper−Doxorubicin as a Nanoparticle Cargo Retains Efficacy with Minimal Toxicity
2010
Synergistic Cytotoxicity of Irinotecan and Cisplatin in Dual-Drug Targeted Polymeric Nanoparticles
2012
Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
2011 Standout
Analysis of cause of failure of new targeting peptide in PEGylated liposome: Molecular modeling as rational design tool for nanomedicine
2012
Cryogenic Transmission Electron Microscopy for Direct Observation of Polymer and Small-Molecule Materials and Structures in Solution
2010
68Ga Small Peptide Imaging: Comparison of NOTA and PCTA
2012
Ratiometric dosing of anticancer drug combinations: Controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice
2006
Plant Secondary Metabolites as Anticancer Agents: Successes in Clinical Trials and Therapeutic Application
2018 Standout
Surface Polyethylene Glycol Conformation Influences the Protein Corona of Polyethylene Glycol-Modified Single-Walled Carbon Nanotubes: Potential Implications on Biological Performance
2013
Imaging Tumor Vasculature Noninvasively with Positron Emission Tomography and RGD Peptides Labeled with Copper 64 Using the Bifunctonal Chelates DOTA, Oxo-DO3A. and PCTA
2013
Works of Malathi Anantha being referenced
A novel approach to prepare a liposomal irinotecan formulations that exhibit significant therapeutic activity in vivo
2004
Liposomal formulations of carboplatin injected by convection-enhanced delivery increases the median survival time of F98 glioma bearing rats
2018
Optimization of liposomal topotecan for use in treating neuroblastoma
2017
Vascular normalization in orthotopic glioblastoma following intravenous treatment with lipid-based nanoparticulate formulations of irinotecan (Irinophore C™), doxorubicin (Caelyx®) or vincristine
2011
Irinophore C™, a lipid nanoparticulate formulation of irinotecan, improves vascular function, increases the delivery of sequentially administered 5-FU in HT-29 tumors, and controls tumor growth in patient derived xenografts of colon cancer
2014
Irinotecan–cisplatin interactions assessed in cell-based screening assays: cytotoxicity, drug accumulation and DNA adduct formation in an NSCLC cell line
2006
Transition Metal-Mediated Liposomal Encapsulation of Irinotecan (CPT-11) Stabilizes the Drug in the Therapeutically Active Lactone Conformation
2006
Copper–topotecan complexation mediates drug accumulation into liposomes
2006
Characterization of Cationic Liposome Formulations Designed to Exhibit Extended Plasma Residence Times and Tumor Vasculature Targeting Properties
2010
Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: Relating plasma circulation lifetimes to protein binding
2007
Irinophore C, a Novel Nanoformulation of Irinotecan, Alters Tumor Vascular Function and Enhances the Distribution of 5-Fluorouracil and Doxorubicin
2008